SWM
TMO icon

Stockman Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Stockman Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-387
Closed -$224K – 190
2025
Q4 		$224K Buy
+387
New +$219K 0.03% 167
2025
Q1 		– Sell
-427
Closed -$222K – 174
2024
Q4 		$222K Hold
427
– – 0.03% 150
2024
Q3 		$264K Sell
427
-3
-0.7% -$1.78K 0.04% 151
2024
Q2 		$238K Sell
430
-50
-10% -$28.6K 0.04% 153
2024
Q1 		$279K Sell
480
-12
-2% -$6.73K 0.05% 147
2023
Q4 		$261K Sell
492
-18
-4% -$8.71K 0.05% 145
2023
Q3 		$258K Buy
510
+18
+4% +$9.59K 0.06% 151
2023
Q2 		$257K Sell
492
-2
-0.4% -$1.08K 0.06% 163
2023
Q1 		$285K Sell
494
-23
-4% -$13K 0.06% 163
2022
Q4 		$285K Sell
517
-13
-2% -$6.89K 0.07% 154
2022
Q3 		$269K Sell
530
-15
-3% -$8.39K 0.07% 150
2022
Q2 		$296K Hold
545
– – 0.08% 141
2022
Q1 		$322K Buy
545
+105
+24% +$60.3K 0.07% 153
2021
Q4 		$294K Sell
440
-12
-3% -$7.49K 0.06% 161
2021
Q3 		$258K Sell
452
-90
-17% -$49.4K 0.06% 172
2021
Q2 		$273K Buy
542
+90
+20% +$42.5K 0.07% 160
2021
Q1 		$206K Sell
452
-106
-19% -$50.6K 0.06% 177
2020
Q4 		$260K Buy
+558
New +$262K 0.08% 150

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Stockman Wealth Management's TMO Position: Q1 2026 in Review

Stockman Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 387 shares — an estimated $224K sold.

Stockman Wealth Management first reported a position in TMO in Q4 2020 and held it in 18 quarters. The position peaked at $322K in Q1 2022. 2,612 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Stockman Wealth Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Stockman Wealth Management sold 387 Thermo Fisher Scientific shares in Q1 2026, an estimated $224K.
  • Stockman Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 18 quarters.
  • Stockman Wealth Management's Thermo Fisher Scientific position peaked at $322K in Q1 2022.
  • 2,612 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Stockman Wealth Management's 13F filing for Q1 2026, filed 13 Apr 2026.